| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Role of calcium in neurotensin-evoked enhancement in firing in mesencephalic dopamine neurons.
|
J Neurosci
|
2004
|
0.90
|
|
2
|
Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
|
Neuropsychopharmacology
|
2006
|
0.89
|
|
3
|
Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials.
|
Int Clin Psychopharmacol
|
2011
|
0.88
|
|
4
|
Blockade of mGLUR5 receptors differentially alters amphetamine-induced enhancement of locomotor activity and of brain stimulation reward.
|
J Psychopharmacol
|
2010
|
0.83
|
|
5
|
Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis.
|
J Clin Psychopharmacol
|
2010
|
0.82
|
|
6
|
Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study.
|
Psychiatry Res
|
2007
|
0.81
|
|
7
|
Blockade of ventral midbrain NMDA receptors enhances brain stimulation reward: a preferential role for GluN2A subunits.
|
Eur Neuropsychopharmacol
|
2013
|
0.81
|
|
8
|
Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.
|
Front Syst Neurosci
|
2013
|
0.80
|
|
9
|
Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial.
|
Expert Opin Pharmacother
|
2010
|
0.79
|
|
10
|
The transcription factors Nur77 and retinoid X receptors participate in amphetamine-induced locomotor activities.
|
Psychopharmacology (Berl)
|
2008
|
0.79
|
|
11
|
Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotion.
|
Eur Neuropsychopharmacol
|
2009
|
0.78
|
|
12
|
Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
|
Psychopharmacology (Berl)
|
2003
|
0.78
|
|
13
|
Quetiapine blocks cocaine-induced enhancement of brain stimulation reward.
|
Behav Brain Res
|
2009
|
0.78
|
|
14
|
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.
|
Front Psychiatry
|
2011
|
0.77
|
|
15
|
Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
|
Eur Neuropsychopharmacol
|
2010
|
0.76
|
|
16
|
Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents.
|
Front Pharmacol
|
2012
|
0.76
|
|
17
|
Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation.
|
Brain Res
|
2004
|
0.76
|
|
18
|
Cross-fostering does not alter the differential sensitivity of Fischer and Lewis rats to central neurotensin-induced locomotion and hypothermia.
|
Behav Brain Res
|
2006
|
0.76
|
|
19
|
Effects of excitotoxic lesions of the medial prefrontal cortex on density of high affinity [125I-Tyr3]neurotensin binding sites within the ventral midbrain and striatum.
|
Eur J Pharmacol
|
2006
|
0.76
|
|
20
|
Neurobiology of severe mental disorders: from cell to bedside 25th International Symposium of the Centre de recherche en sciences neurologiques, Université de Montréal.
|
J Psychiatry Neurosci
|
2004
|
0.75
|
|
21
|
Mesencephalic substrate of reward: possible role for lateral pontine tegmental cells.
|
Brain Res
|
2002
|
0.75
|
|
22
|
Evidence for a role of endogenous neurotensin in the development of sensitization to the locomotor stimulant effect of morphine.
|
Eur J Pharmacol
|
2008
|
0.75
|
|
23
|
Evidence that the reward attenuating effect of the D1-like antagonist, SCH-23390, is not mediated by its agonist action at the 5-HT2c receptors.
|
Behav Brain Res
|
2010
|
0.75
|
|
24
|
Neurotensin modulation of spontaneous EPSCs in the nucleus accumbens of Lewis and Fischer 344 rats.
|
Peptides
|
2008
|
0.75
|